Previous studies determined that IL-6-induced SOCS3 dysfunction and sustained activation of the JAK/STAT signaling pathway promoted the amplification and immunosuppressive function of breast cancer MDSCs in vitro and in vivo29. The gene discussed is SOCS3; the disease is breast carcinoma.